D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 11.63% |
| 3 | Healthcare | 11.01% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONDK
1801
DELISTED
On Deck Capital, Inc.
ONDK
| $3.05M | ﹤0.01% |
516,161
-56,997
| -10% | -$405K |
|
1802
CALL
WD-40
WDFC
$2.98B
| $3.04M | ﹤0.01% |
16,600
-7,000
| -30% | -$1.19M |
|
1803
CALL
Jack Henry & Associates
JKHY
$11.4B
| $3.04M | ﹤0.01% |
24,000
-3,500
| -13% | -$497K |
|
1804
MidCap Financial Investment
MFIC
$801M
| $3.04M | ﹤0.01% |
244,855
-57,867
| -19% | -$881K |
|
1805
PUT
ScottsMiracle-Gro
SMG
$4.09B
| $3.04M | ﹤0.01% |
49,400
+34,900
| +241% | +$2.48M |
|
1806
CALL
Cleveland-Cliffs
CLF
$6.49B
| $3.03M | ﹤0.01% |
394,500
-50,300
| -11% | -$503K |
|
|
INVX
1807
Innovex International
INVX
$1.8B
| $3.03M | ﹤0.01% |
101,014
+30,552
| +43% | +$1.23M |
|
|
ISEE
1808
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.03M | ﹤0.01% |
2,521,995
-109,122
| -4% | -$211K |
|
1809
CALL
International Paper
IP
$22.6B
| $3.02M | ﹤0.01% |
79,094
+27,139
| +52% | +$1.14M |
|
|
ARC
1810
DELISTED
ARC Document Solutions, Inc.
ARC
| $3.02M | ﹤0.01% |
1,474,585
-14,395
| -1% | -$35.1K |
|
1811
Eversource Energy
ES
$28.1B
| $3.02M | ﹤0.01% |
46,376
-47,190
| -50% | -$3.07M |
|
1812
Prospect Capital
PSEC
$1.08B
| $3.01M | ﹤0.01% |
477,352
| – | – |
|
|
BLD
1813
CALL
DELISTED
TopBuild
BLD
| $3.01M | ﹤0.01% |
+66,800
| New | +$3.25M |
|
|
INWK
1814
DELISTED
InnerWorkings, Inc.
INWK
| $3M | ﹤0.01% |
802,420
+393,991
| +96% | +$2.19M |
|
|
I
1815
PUT
DELISTED
INTELSAT S. A.
I
| $3M | ﹤0.01% |
140,300
+26,500
| +23% | +$716K |
|
1816
CALL
DexCom
DXCM
$29B
| $3M | ﹤0.01% |
100,000
+20,000
| +25% | +$634K |
|
1817
PUT
Cardinal Health
CAH
$53.7B
| $2.99M | ﹤0.01% |
67,000
| – | – |
|
1818
CALL
Ubiquiti
UI
$31.6B
| $2.98M | ﹤0.01% |
30,000
+5,000
| +20% | +$495K |
|
|
BOLD
1819
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.98M | ﹤0.01% |
139,641
+74,529
| +114% | +$1.92M |
|
|
ALTR
1820
DELISTED
Altair Engineering Inc
ALTR
| $2.97M | ﹤0.01% |
107,845
-124,621
| -54% | -$4.11M |
|
1821
Lesaka Technologies
LSAK
$384M
| $2.96M | ﹤0.01% |
630,447
-278,955
| -31% | -$1.64M |
|
1822
ATN International
ATNI
$365M
| $2.95M | ﹤0.01% |
41,230
-4,861
| -11% | -$380K |
|
1823
Expro Ltd
XPRO
$1.66B
| $2.94M | ﹤0.01% |
93,961
+80,118
| +579% | +$3.48M |
|
|
ABMD
1824
DELISTED
Abiomed Inc
ABMD
| $2.92M | ﹤0.01% |
8,992
+2,122
| +31% | +$737K |
|
1825
A10 Networks
ATEN
$2.07B
| $2.92M | ﹤0.01% |
467,964
+77,786
| +20% | +$471K |
|
Similar funds
D.E. Shaw & Co's Q4 2018 Portfolio in Review
As of Q4 2018, D.E. Shaw & Co held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
D.E. Shaw & Co deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- D.E. Shaw & Co's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- D.E. Shaw & Co added most to Oracle in Q4 2018, an estimated $431M increase.
- D.E. Shaw & Co's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- D.E. Shaw & Co fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- D.E. Shaw & Co's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- D.E. Shaw & Co opened 541 new positions and closed 497 in Q4 2018.
- D.E. Shaw & Co's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.